FDA's 2026 Food Priorities – FDA Watch
Wayne chats with David Lennarz, President of Registrar Corp., and Dr. Susan Mayne, Adjunct Professor at the Yale School of Public Health and former Director of FDA’s Center for Food Safety and Applied Nutrition. You’ll hear their thoughts on the Human Foods Program’s 2026 priority deliverables; how the new food pyramid/dietary guidelines may impact food and nutrition policy; the state of FDA’s focus on food dyes; the latest labeling and ingredient disclosure; the direction of infant formula following recent recalls; GRAS reform and general food safety oversight; and much more.
Headlines
FDA reports efficiencies with ImportShield Program
Pharma: FDA and EMA jointly issue 10 guiding principles on AI in drug and biologics development
Devices: FDA increases scrutiny of direct-to-consumer self-collection kits by treating certain collection devices as regulated medical devices
Food: FDA’s Human Foods Program released 2026 priority deliverables
Cosmetics: Cosmetics products potentially exposed to rodents and rodent activity at Minnesota distribution facility
Resource Links
Pharma: PharmaVoice Q&A with Genevieve Kanter on current FDA climate
Devices: AdvaMed honors retiring executive Janet Trunzo
Food: RFI for gluten-containing ingredient labeling
Cosmetics: HBW Insight Q&A with Venable partner and FDA group co-chair Claudia Lewis
About Our Guests
Dr. Susan Mayne
Susan Mayne, Ph.D., is currently Professor (Adjunct) at the Yale School of Public Health, and from 2015-2023 she Directed the FDA Center for Food Safety and Applied Nutrition. Prior to joining the FDA, she spent nearly three decades at the Yale School of Public Health focusing on food and nutrition.
David Lennarz
David Lennarz is the President at Registrar Corp. He manages the company’s overseas operations. He has worked for almost 22 years in FDA-regulated industries in the U.S. and Europe.
FDA Watch Podcast 